Literature DB >> 6362828

The whys of cancer quackery.

I J Lerner.   

Abstract

The nation appears to have weathered the laetrile phenomenon. In just having passed through the greatest episode of quackery in our history, it would be appropriate to reflect on the whys of quackery: Why do some promote it? Why do so many use it? Why should the medical profession care? Using the laetrile experience as a model, the author attempts to deal with these fundamental questions, and tries in particular to sort out which factors were unique to laetrile and which factors have always been associated with quack promotions and are likely to continue. When a successful quack promotion is analyzed, a complex interplay of failures on the part of physicians and the public is observed, and the triumphs of the promoters are recognized. Finally, it is necessary to deal with the issue of the responsibility of the individual physician and of the profession in general in coping with an unsound, antiscientific medical therapeutic.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6362828     DOI: 10.1002/1097-0142(19840201)53:3+<815::aid-cncr2820531334>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Perceived health quackery use among patients. A physician survey.

Authors:  R Nishiwaki; A Morton; C Bouchard; J A Peters; W T Jarvis
Journal:  West J Med       Date:  1990-01

2.  The rise of people power.

Authors:  Roger Chafe; Karen B Born; Arthur S Slutsky; Andreas Laupacis
Journal:  Nature       Date:  2011-04-28       Impact factor: 49.962

Review 3.  Unconventional cancer remedies.

Authors:  K J Danielson; D E Stewart; G P Lippert
Journal:  CMAJ       Date:  1988-06-01       Impact factor: 8.262

4.  Physicians' attitudes toward patients' use of alternative cancer therapies.

Authors:  I L Bourgeault
Journal:  CMAJ       Date:  1996-12-15       Impact factor: 8.262

5.  Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment.

Authors:  S M Downer; M M Cody; P McCluskey; P D Wilson; S J Arnott; T A Lister; M L Slevin
Journal:  BMJ       Date:  1994-07-09

6.  The association between mental distress and the use of alternative medicine among cancer patients in North Norway.

Authors:  T Risberg; B K Jacobsen
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

7.  Compassionate use of experimental therapies: who should decide?

Authors:  Patricia J Zettler
Journal:  EMBO Mol Med       Date:  2015-10       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.